| 1 |
Modulation of Antibody Galactosylation Through Feeding of Uridine, Manganese Chloride, and Galactose
Gramer MJ, Eckblad JJ, Donahue R, Brown J, Shultz C, Vickerman K, Priem P, van den Bremer ETJ, Gerritsen J, van Berkel PHC
Biotechnology and Bioengineering, 108(7), 1591, 2011 |
| 2 |
Optimal NSO cell growth in a hollow fiber bioreactor requires increased serum concentration or a cholesterol supplement on the cell side of the fiber
Gramer MJ, Maas J
Biotechnology Progress, 19(6), 1762, 2003 |
| 3 |
Antibody production by a hybridoma cell line at high cell density is limited by two independent mechanisms
Gramer MJ, Britton TL
Biotechnology and Bioengineering, 79(3), 277, 2002 |
| 4 |
Effect of harvesting protocol on performance of a hollow fiber bioreactor
Gramer MJ, Poeschl DM, Conroy MJ, Hammer BE
Biotechnology and Bioengineering, 65(3), 334, 1999 |
| 5 |
Screening tool for hollow-fiber bioreactor process development
Gramer MJ, Poeschl DM
Biotechnology Progress, 14(2), 203, 1998 |
| 6 |
Glycosidase Activities of the 293 and Ns0 Cell-Lines, and of an Antibody-Producing Hybridoma Cell-Line
Gramer MJ, Goochee CF
Biotechnology and Bioengineering, 43(5), 423, 1994 |
